Off-Label Anti-VEGF Therapy: Targeting New Conditions
The decision to use an approved drug for a new indication gets to the heart of the practice of medicine. It's legal, and doctors do it every day, exercising their clinical judgment and acumen. The expansion of anti-VEGF drugs across a multitude of conditions is a case in point—and it raises important questions about when to use a drug and when to think twice.
